Siyan Clinical Research
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 108,151 | 201,274 | −93,123 | -5.4 | — |
| 2018 | 548,452 | 579,465 | −31,013 | -2.5 | 81% |
| 2019 | 1,370,261 | 1,232,262 | 137,999 | 0.2 | 74% |
| 2020 | 1,597,190 | 1,435,824 | 161,366 | 1.5 | 69% |
| 2021 | 1,496,970 | 1,482,019 | 14,951 | 0.5 | 67% |
| 2022 | 816,765 | 994,435 | −177,670 | -1.3 | 19% |
| 2023 | 1,457,279 | 1,514,494 | −57,215 | -1.3 | 64% |
In its most recent public year (2023), this organization spent $57,215 more than it brought in. Its liabilities exceeded its net assets — reserves were below zero (-1.3 months), up from -5.4 in 2017. Staff pay was 64% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Siyan Clinical Research's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works